In Vivo Toxicology Market Size, Share & Trends Analysis Report By Product (Instruments & Equipment, Consumables), By Toxicology Testing, By Animal Model (Rodent, Non-Rodent Mammals), By Application, By Region, And Segment Forecasts, 2026 - 2033

August 2026 | 150 pages | ID: I3EBB154A80EEN
Grand View Research, Inc.

Abstracts

The global in vivo toxicology market size was valued at USD 5.3 billion in 2025 and is projected to grow from USD 5.7 billion in 2026 to USD 9.9 billion by 2033, at a CAGR of 8.2% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 41.2% in 2025. The market growth is driven by the increasing demand for in vivo toxicology industry in preclinical safety and toxicity assessment across pharmaceutical and biotechnology development.

The in vivo toxicology industry is witnessing significant growth, driven by increasing demand for preclinical safety assessment in pharmaceutical and biopharmaceutical drug development. Growing investment in drug discovery, expanding pipelines of novel therapeutics, and the need to evaluate toxicity and potential adverse effects before clinical trials are supporting market expansion. Continuous advancements in digital animal monitoring, sensor technologies, artificial intelligence, and machine learning are also improving the efficiency and effectiveness of in vivo toxicology studies, supporting market growth over the forecast period.

Global In Vivo Toxicology Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global in vivo toxicology market report based on product, toxicology testing, animal model, application, and region.

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
• Instruments & Equipment
• Consumables
• Toxicology Testing Services
• Toxicology Testing Outlook (Revenue, USD Billion, 2021 - 2033)
• Acute Toxicity
• Repeated-Dose/Systemic Toxicity
• Reproductive & Developmental Toxicity
• Genotoxicity
• Carcinogenicity
• Immunotoxicity
• Other Specialized & Target-Organ Toxicity
• Animal Model Outlook (Revenue, USD Billion, 2021 - 2033)
• Rodents
• Non-Rodents Mammals
• Non-Mammalian Models
• Application Outlook (Revenue, USD Billion, 2021 - 2033)
• Pharmaceuticals & Biotechnology
• Chemicals & Agrochemicals
• Food & Nutrition
• Medical Devices
• Other Applications
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• Thailand
• South Korea
• Latin America
• Brazil
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

This report can be delivered to the clients within 3 Business Days

Contents

CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation and Scope
  1.1.1. Segment Definitions
  1.1.1.1. Product Segment
  1.1.1.2. Toxicology Testing Segment
  1.1.1.3. Animal Model Segment
  1.1.1.4. Application Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.5. Research Methodology
1.6. Information Procurement
  1.6.1. Purchased Database
  1.6.2. GVR’s Internal Database
  1.6.3. Secondary Sources
  1.6.4. Primary Research
1.7. Information or Data Analysis:
  1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
  1.9.1. Commodity Flow Analysis
  1.9.2. List of Secondary Sources
  1.9.3. List of Abbreviations

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE

3.1. Market Lineage Outlook
  3.1.1. Parent Market Outlook
  3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
  3.2.1. Market Driver Analysis
  3.2.1.1. Increasing Adoption of Digital Technologies in Preclinical Animal Studies
  3.2.1.2. Growing Focus on Drug Safety and Early Toxicity Detection
  3.2.1.3. Increasing Adoption of Translational and Predictive Toxicology Approaches
  3.2.2. Market Restraint Analysis
  3.2.2.1. Growing Regulatory and Ethical Restrictions on Animal Testing
  3.2.2.2. High Cost and Time-Intensive Nature of In Vivo Toxicology Studies
  3.2.3. Market Opportunities Analysis
  3.2.4. Market Challenges Analysis
3.3. Industry Analysis Tools
  3.3.1. Porter’s Five Forces Analysis
  3.3.1.1. Supplier power
  3.3.1.2. Buyer power
  3.3.1.3. Substitution threat
  3.3.1.4. Threat of new entrant
  3.3.1.5. Competitive rivalry
  3.3.2. PESTLE Analysis
  3.3.2.1. Political landscape
  3.3.2.2. Technological landscape
  3.3.2.3. Social landscape
  3.3.2.4. Economic landscape
  3.3.2.5. Legal landscape
  3.3.2.6. Environmental landscape

CHAPTER 4. PRODUCT BUSINESS ANALYSIS

4.1. Segment Dashboard
4.2. In Vivo Toxicology Market: Product Movement Analysis
4.3. Instruments & Equipment
  4.3.1. Instruments & Equipment Market, 2021–2033 (USD Billion)
4.4. Consumables
  4.4.1. Consumables Market, 2021–2033 (USD Billion)
4.5. Toxicology Testing Services
  4.5.1. Toxicology Testing Services Market, 2021–2033 (USD Billion)

CHAPTER 5. TOXICOLOGY TESTING BUSINESS ANALYSIS

5.1. Segment Dashboard
5.2. In Vivo Toxicology Market: Toxicology Testing Movement Analysis
5.3. Acute Toxicity
  5.3.1. Acute Toxicity Market, 2021–2033 (USD Billion)
5.4. Repeated-Dose/Systemic Toxicity
  5.4.1. Repeated-Dose/Systemic Toxicity Market, 2021–2033 (USD Billion)
5.5. Reproductive & Developmental Toxicity
  5.5.1. Reproductive & Developmental Toxicity Market, 2021–2033 (USD Billion)
5.6. Genotoxicity
  5.6.1. Genotoxicity Market, 2021–2033 (USD Billion)
5.7. Carcinogenicity
  5.7.1. Carcinogenicity Market, 2021–2033 (USD Billion)
5.8. Immunotoxicity
  5.8.1. Immunotoxicity Market, 2021–2033 (USD Billion)
5.9. Other Specialized & Target-Organ Toxicity
  5.9.1. Other Specialized & Target-Organ Toxicity Market, 2021–2033 (USD Billion)

CHAPTER 6. ANIMAL MODEL BUSINESS ANALYSIS

6.1. Segment Dashboard
6.2. In Vivo Toxicology Market: Animal Model Movement Analysis
6.3. Rodents
  6.3.1. Rodents Market, 2021–2033 (USD Billion)
6.4. Non-Rodent Mammals
  6.4.1. Non-Rodent Mammals Market, 2021–2033 (USD Billion)
6.5. Non-Mammalian Models
  6.5.1. Non-Mammalian Models Market, 2021–2033 (USD Billion)

CHAPTER 7. APPLICATION BUSINESS ANALYSIS

7.1. Segment Dashboard
7.2. In Vivo Toxicology Market: Application Analysis
7.3. Pharmaceuticals & Biotechnology
  7.3.1. Pharmaceuticals & Biotechnology Market, 2021–2033 (USD Billion)
7.4. Chemicals & Agrochemicals
  7.4.1. Chemicals & Agrochemicals Market, 2021–2033 (USD Billion)
7.5. Food & Nutrition
  7.5.1. Food & Nutrition Market, 2021–2033 (USD Billion)
7.6. Medical Devices
  7.6.1. Medical Devices Market, 2021–2033 (USD Billion)
7.7. Other Applications
  7.7.1. Other Applications Market, 2021–2033 (USD Billion)

CHAPTER 8. REGIONAL BUSINESS ANALYSIS

8.1. In Vivo Toxicology Market Share By Region, 2025 & 2033
8.2. North America
  8.2.1. North America In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.2.2. U.S.
  8.2.2.1. Key Country Dynamics
  8.2.2.2. Competitive Scenario
  8.2.2.3. Regulatory Framework
  8.2.2.4. U.S. In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.2.3. Canada
  8.2.3.1. Key Country Dynamics
  8.2.3.2. Competitive Scenario
  8.2.3.3. Regulatory Framework
  8.2.3.4. Canada In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.2.4. Mexico
  8.2.4.1. Key Country Dynamics
  8.2.4.2. Competitive Scenario
  8.2.4.3. Regulatory Framework
  8.2.4.4. Mexico In Vivo Toxicology Market, 2021-2033 (USD Billion)
8.3. Europe
  8.3.1. Europe In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.3.2. UK
  8.3.2.1. Key Country Dynamics
  8.3.2.2. Competitive Scenario
  8.3.2.3. Regulatory Framework
  8.3.2.4. UK In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.3.3. Germany
  8.3.3.1. Key Country Dynamics
  8.3.3.2. Competitive Scenario
  8.3.3.3. Regulatory Framework
  8.3.3.4. Germany In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.3.4. France
  8.3.4.1. Key Country Dynamics
  8.3.4.2. Competitive Scenario
  8.3.4.3. Regulatory Framework
  8.3.4.4. France In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.3.5. Italy
  8.3.5.1. Key Country Dynamics
  8.3.5.2. Competitive Scenario
  8.3.5.3. Regulatory Framework
  8.3.5.4. Italy In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.3.6. Spain
  8.3.6.1. Key Country Dynamics
  8.3.6.2. Competitive Scenario
  8.3.6.3. Regulatory Framework
  8.3.6.4. Spain In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.3.7. Denmark
  8.3.7.1. Key Country Dynamics
  8.3.7.2. Competitive Scenario
  8.3.7.3. Regulatory Framework
  8.3.7.4. Denmark In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.3.8. Sweden
  8.3.8.1. Key Country Dynamics
  8.3.8.2. Competitive Scenario
  8.3.8.3. Regulatory Framework
  8.3.8.4. Sweden In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.3.9. Norway
  8.3.9.1. Key Country Dynamics
  8.3.9.2. Competitive Scenario
  8.3.9.3. Regulatory Framework
  8.3.9.4. Norway In Vivo Toxicology Market, 2021-2033 (USD Billion)
8.4. Asia Pacific
  8.4.1. Asia Pacific In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.4.2. Japan
  8.4.2.1. Key Country Dynamics
  8.4.2.2. Competitive Scenario
  8.4.2.3. Regulatory Framework
  8.4.2.4. Japan In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.4.3. China
  8.4.3.1. Key Country Dynamics
  8.4.3.2. Competitive Scenario
  8.4.3.3. Regulatory Framework
  8.4.3.4. China In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.4.4. India
  8.4.4.1. Key Country Dynamics
  8.4.4.2. Competitive Scenario
  8.4.4.3. Regulatory Framework
  8.4.4.4. India In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.4.5. Australia
  8.4.5.1. Key Country Dynamics
  8.4.5.2. Competitive Scenario
  8.4.5.3. Regulatory Framework
  8.4.5.4. Australia In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.4.6. Thailand
  8.4.6.1. Key Country Dynamics
  8.4.6.2. Competitive Scenario
  8.4.6.3. Regulatory Framework
  8.4.6.4. Thailand In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.4.7. South Korea
  8.4.7.1. Key Country Dynamics
  8.4.7.2. Competitive Scenario
  8.4.7.3. Regulatory Framework
  8.4.7.4. South Korea In Vivo Toxicology Market, 2021-2033 (USD Billion)
8.5. Latin America
  8.5.1. Latin America In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.5.2. Brazil
  8.5.2.1. Key Country Dynamics
  8.5.2.2. Competitive Scenario
  8.5.2.3. Regulatory Framework
  8.5.2.4. Brazil In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.5.3. Argentina
  8.5.3.1. Key Country Dynamics
  8.5.3.2. Competitive Scenario
  8.5.3.3. Regulatory Framework
  8.5.3.4. Argentina In Vivo Toxicology Market, 2021-2033 (USD Billion)
8.6. MEA
  8.6.1. MEA In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.6.2. South Africa
  8.6.2.1. Key Country Dynamics
  8.6.2.2. Competitive Scenario
  8.6.2.3. Regulatory Framework
  8.6.2.4. South Africa In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.6.3. Saudi Arabia
  8.6.3.1. Key Country Dynamics
  8.6.3.2. Competitive Scenario
  8.6.3.3. Regulatory Framework
  8.6.3.4. Saudi Arabia In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.6.4. UAE
  8.6.4.1. Key Country Dynamics
  8.6.4.2. Competitive Scenario
  8.6.4.3. Regulatory Framework
  8.6.4.4. UAE In Vivo Toxicology Market, 2021-2033 (USD Billion)
  8.6.5. Kuwait
  8.6.5.1. Key Country Dynamics
  8.6.5.2. Competitive Scenario
  8.6.5.3. Regulatory Framework
  8.6.5.4. Kuwait In Vivo Toxicology Market, 2021-2033 (USD Billion)

CHAPTER 9. COMPETITIVE LANDSCAPE

9.1. Company Categorization
9.2. Company Market Share/ Position Analysis, 2025
9.3. Strategy Mapping
9.4. Company Profiles/Listing
  9.4.1. Charles River Laboratories
  9.4.1.1. Overview
  9.4.1.2. Financial Performance
  9.4.1.3. Product Benchmarking
  9.4.1.4. Strategic Initiatives
  9.4.2. Labcorp
  9.4.2.1. Overview
  9.4.2.2. Financial Performance
  9.4.2.3. Product Benchmarking
  9.4.2.4. Strategic Initiatives
  9.4.3. WuXi AppTec
  9.4.3.1. Overview
  9.4.3.2. Financial Performance
  9.4.3.3. Product Benchmarking
  9.4.3.4. Strategic Initiatives
  9.4.4. Inotiv
  9.4.4.1. Overview
  9.4.4.2. Financial Performance
  9.4.4.3. Product Benchmarking
  9.4.4.4. Strategic Initiatives
  9.4.5. Pharmaron
  9.4.5.1. Overview
  9.4.5.2. Financial Performance
  9.4.5.3. Product Benchmarking
  9.4.5.4. Strategic Initiatives
  9.4.6. Altasciences
  9.4.6.1. Overview
  9.4.6.2. Financial Performance
  9.4.6.3. Product Benchmarking
  9.4.6.4. Strategic Initiatives
  9.4.7. Eurofins
  9.4.7.1. Overview
  9.4.7.2. Financial Performance
  9.4.7.3. Product Benchmarking
  9.4.7.4. Strategic Initiatives
  9.4.8. Evotec
  9.4.8.1. Overview
  9.4.8.2. Financial Performance
  9.4.8.3. Product Benchmarking
  9.4.8.4. Strategic Initiatives
  9.4.9. Aragen Life Sciences Ltd.
  9.4.9.1. Overview
  9.4.9.2. Financial Performance
  9.4.9.3. Product Benchmarking
  9.4.9.4. Strategic Initiatives
  9.4.10. Jubilant Biosys Limited
  9.4.10.1. Overview
  9.4.10.2. Financial Performance
  9.4.10.3. Product Benchmarking
  9.4.10.4. Strategic Initiatives
  9.4.11. The Jackson Laboratory
  9.4.11.1. Overview
  9.4.11.2. Financial Performance
  9.4.11.3. Product Benchmarking
  9.4.11.4. Strategic Initiatives
  9.4.12. Taconic Biosciences, Inc.
  9.4.12.1. Overview
  9.4.12.2. Financial Performance
  9.4.12.3. Product Benchmarking
  9.4.12.4. Strategic Initiatives
  9.4.13. Bruker
  9.4.13.1. Overview
  9.4.13.2. Financial Performance
  9.4.13.3. Product Benchmarking
  9.4.13.4. Strategic Initiatives
  9.4.14. Data Sciences International
  9.4.14.1. Overview
  9.4.14.2. Financial Performance
  9.4.14.3. Product Benchmarking
  9.4.14.4. Strategic Initiatives

List Of Tables

LIST OF TABLES

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 4 Global in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 5 Global in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 6 Global in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 7 Global in vivo toxicology market, by region, 2021 - 2033 (USD billion)
Table 8 North America in vivo toxicology market, by country, 2021 - 2033 (USD billion)
Table 9 North America in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 10 North America in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 11 North America in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 12 North America in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 13 U.S. in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 14 U.S. in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 15 U.S. in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 16 U.S. in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 17 Canada in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 18 Canada in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 19 Canada in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 20 Canada in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 21 Mexico in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 22 Mexico in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 23 Mexico in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 24 Mexico in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 25 Europe in vivo toxicology market, by country, 2021 - 2033 (USD billion)
Table 26 Europe in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 27 Europe in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 28 Europe in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 29 Europe in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 30 UK in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 31 UK in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 32 UK in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 33 UK in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 34 Germany in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 35 Germany in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 36 Germany in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 37 Germany in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 38 France in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 39 France in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 40 France in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 41 France in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 42 Italy in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 43 Italy in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 44 Italy in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 45 Italy in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 46 Spain in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 47 Spain in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 48 Spain in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 49 Spain in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 50 Denmark in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 51 Denmark in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 52 Denmark in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 53 Denmark in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 54 Sweden in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 55 Sweden in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 56 Sweden in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 57 Sweden in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 58 Norway in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 59 Norway in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 60 Norway in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 61 Norway in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 62 Asia Pacific in vivo toxicology market, by country, 2021 - 2033 (USD billion)
Table 63 Asia Pacific in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 64 Asia Pacific in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 65 Asia Pacific in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 66 Asia Pacific in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 67 Japan in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 68 Japan in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 69 Japan in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 70 Japan in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 71 China in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 72 China in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 73 China in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 74 China in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 75 India in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 76 India in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 77 India in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 78 India in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 79 Australia in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 80 Australia in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 81 Australia in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 82 Australia in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 83 Thailand in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 84 Thailand in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 85 Thailand in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 86 Thailand in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 87 South Korea in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 88 South Korea in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 89 South Korea in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 90 South Korea in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 91 Latin America in vivo toxicology market, by country, 2021 - 2033 (USD billion)
Table 92 Latin America in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 93 Latin America in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 94 Latin America in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 95 Latin America in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 96 Brazil in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 97 Brazil in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 98 Brazil in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 99 Brazil in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 100 Argentina in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 101 Argentina in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 102 Argentina in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 103 Argentina in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 104 Middle East & Africa in vivo toxicology market, by country, 2021 - 2033 (USD billion)
Table 105 Middle East & Africa in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 106 Middle East & Africa in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 107 Middle East & Africa in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 108 Middle East & Africa in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 109 South Africa in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 110 South Africa in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 111 South Africa in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 112 South Africa in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 113 Saudi Arabia in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 114 Saudi Arabia in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 115 Saudi Arabia in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 116 Saudi Arabia in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 117 UAE in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 118 UAE in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 119 UAE in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 120 UAE in vivo toxicology market, by application, 2021 - 2033 (USD billion)
Table 121 Kuwait in vivo toxicology market, by product, 2021 - 2033 (USD billion)
Table 122 Kuwait in vivo toxicology market, by toxicology testing, 2021 - 2033 (USD billion)
Table 123 Kuwait in vivo toxicology market, by animal model, 2021 - 2033 (USD billion)
Table 124 Kuwait in vivo toxicology market, by application, 2021 - 2033 (USD billion)

List Of Figures

LIST OF FIGURES

Fig. 1 In vivo toxicology market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Parent market outlook
Fig. 11 In vivo toxicology market driver analysis
Fig. 12 In vivo toxicology market restraint analysis
Fig. 13 In vivo toxicology market: Porter's five forces analysis
Fig. 14 In vivo toxicology market: PESTLE analysis
Fig. 15 In vivo toxicology market: product outlook and key takeaways
Fig. 16 In vivo toxicology market: product market share analysis
Fig. 17 Instruments & equipment market, 2021 - 2033 (USD billion)
Fig. 18 Consumables market, 2021 - 2033 (USD billion)
Fig. 19 Toxicology testing services market, 2021 - 2033 (USD billion)
Fig. 20 In vivo toxicology market: toxicology testing outlook and key takeaways
Fig. 21 In vivo toxicology market: toxicology testing market share analysis
Fig. 22 Acute toxicity market, 2021 - 2033 (USD billion)
Fig. 23 Repeated dose/systemic toxicity market, 2021 - 2033 (USD billion)
Fig. 24 Reproductive & developmental toxicity market, 2021 - 2033 (USD billion)
Fig. 25 Genotoxicity market, 2021 - 2033 (USD billion)
Fig. 26 Carcinogenicity market, 2021 - 2033 (USD billion)
Fig. 27 Immunotoxicity market, 2021 - 2033 (USD billion)
Fig. 28 Other specialized & target-organ toxicity market, 2021 - 2033 (USD billion)
Fig. 29 In vivo toxicology market: animal model outlook and key takeaways
Fig. 30 In vivo toxicology market: animal model market share analysis
Fig. 31 Rodents market, 2021 - 2033 (USD billion)
Fig. 32 Non-rodent mammals market, 2021 - 2033 (USD billion)
Fig. 33 Non-mammalian models market, 2021 - 2033 (USD billion)
Fig. 34 In vivo toxicology market: application outlook and key takeaways
Fig. 35 In vivo toxicology market: application market share analysis
Fig. 36 Pharmaceuticals & biotechnology market, 2021 - 2033 (USD billion)
Fig. 37 Chemicals & agrochemicals market, 2021 - 2033 (USD billion)
Fig. 38 Food & nutrition market, 2021 - 2033 (USD billion)
Fig. 39 Medical devices market, 2021 - 2033 (USD billion)
Fig. 40 Other applications market, 2021 - 2033 (USD billion)
Fig. 41 Regional marketplace: Key takeaways
Fig. 42 North America in vivo toxicology market, by country, 2021 - 2033 (USD billion)
Fig. 43 U.S. in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 44 Canada in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 45 Mexico in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 46 Europe in vivo toxicology market, by country, 2021 - 2033 (USD billion)
Fig. 47 UK in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 48 Germany in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 49 France in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 50 Italy in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 51 Spain in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 52 Denmark in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 53 Sweden in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 54 Norway in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 55 Asia Pacific in vivo toxicology market, by country, 2021 - 2033 (USD billion)
Fig. 56 Japan in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 57 China in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 58 India in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 59 Australia in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 60 Thailand in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 61 South Korea in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 62 Latin America in vivo toxicology market, by country, 2021 - 2033 (USD billion)
Fig. 63 Brazil in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 64 Argentina in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 65 MEA in vivo toxicology market, by country, 2021 - 2033 (USD billion)
Fig. 66 South Africa in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 67 Saudi Arabia in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 68 UAE in vivo toxicology market, 2021 - 2033 (USD billion)
Fig. 69 Kuwait in vivo toxicology market, 2021 - 2033 (USD billion)